home > news > detailed info

Protagen Protein Services (PPS) expands capabilities for aggregate analytics to include dynamic light scattering (DLS)

Protagen Protein Services

Protein aggregation is a common challenge in the manufacturing of biological products. As one of the most sensitive techniques for the detection of aggregates, dynamic light scattering (DLS) provides a simple, fast and non-destructive testing method. An innovative technique based on a unique cuvette layout allows for accurate measurements with as little as a single µL of solution.

Dynamic light scattering: a powerful risk-management method
From protein expression to storage and delivery, protein aggregation is a process that can occur at any stage in the lifetime of a therapeutic protein. Although the specific mechanisms by which protein aggregation occurs are still not fully understood, various aspects of the manufacturing process, such as microbial contamination during cell culture or inappropriate storage conditions, have been found to increase the risk of physical and chemical degradation due to aggregation.
As protein formation plays a highly critical role in ensuring the usability and efficacy of an injectable biopharmaceutical product, initial formation or aggregation could affect immunogenicity—an important factor in ensuring safety, usability and stability. Incorporating appropriate detection tools at an early stage is a vital step in monitoring potential aggregation.

DLS: beyond current limitations
DLS, a prevalent technique that has been used in both colloidal sciences and protein characterization studies, is the appropriate technique to address the limitations of traditional protein aggregation testing methods.
• Measurements occur directly in the cuvette
• No pretreatment needed
• Effectiveness
     • Only small sample amounts required (< 5 µL per replicate, sample concentration ≥ 0.1 mg/mL)
     • Samples are reusable
• Speed
     • Analysis time: 2 min/sample, resulting in 30 samples/h • Easy and quick data evaluation
     • Highly sensitive to only small amounts of aggregates
• Efficient, high-throughput method

Common measurement techniques vs. dynamic light scattering
Various analytical methods, such as the Coulter counter (CC) method, micro-flow imaging (MFI), dynamic imaging particle analysis (DIPA), and light obscuration (LO), can be applied to evaluate the presence of protein aggregates within the micrometer (μm) range. Multi-angle static light scattering (MALS) allows researchers to measure the presence of protein aggregates early in the formation process. Other common separating methods include asymmetrical flow field-flow fractionation (AF4), analytical ultracentrifugation (AUC) and size-exclusion chromatography (SEC).

Although each of these methods has been proven to be efficient, none of them can directly measure protein aggregates in solution. The specific handling and preparation requirements for the sample, either before or during measurement, can alter the state of sample aggregation.

Dynamic light scattering is simple, fast and non-destructive. A mature and very powerful technique, DLS is based on an analysis of the scattered light fluctuations that occur as a result of Brownian motion. DLS measures the Brownian motion of particles in a dispersion and uses this information to determine their hydrodynamic size.

DLS allows researchers to detect the presence of aggregates, even at very low concentrations. Measurements occur directly in the cuvette and are performed without separation or dilution (preventing potential dissociation of reversible aggregates). No information about concentration or molecular composition is needed.

Applications of DLS

DLS is a high-throughput method suitable for ensemble measurements ranging from Rh values of 0.5 nm up to 1,000 nm. The DynaPro® Nanostar® equipped with DYNAMICS software (Wyatt Technology) is a cuvette-based batch DLS system that enables fast and precise characterization of proteins and requires only small sample volumes.

One of the main application fields for DLS is the detection of aggregates even in trace amounts. Since DLS is a uniquely fast technique, its use for screening during formulation development is particularly common.

The following are some of the diverse applications supported by DLS:
     - Tracing protein aggregation
     - Estimating populations of aggregates in small and large molecules, proteins or liposomes
     - Checking the quality of biomolecules prior to running costly analyses such as SOR or SANS
     - Formulation studies
     - Analyzing thermal stability and denaturation
     - Differentiating pure unfolding from aggregation
     - Measuring the sizes of viruses and VLPs
     - Quantifying self-assembly processes of polypeptides or DNA

Developers particularly benefit from DLS as one of the most sensitive techniques for the detection of aggregates. As a simple, fast, non-destructive, high-throughput screening method, dynamic light scattering yields clear results in a short time and makes it easy to estimate a project’s chances of success.

Learn more from our broad analytical spectrum at

About Protagen Protein Services GmbH:
Protagen Protein Services (PPS) is a world leading CRO and recognized expert in mass spectrometry methods for analytical services in protein science. Over 20 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry. PPS supports Biosimilar developers with a broad range of analytical methods and consulting in achieving and demonstrating Biosimilarity. For developing new biological entities (NBEs) PPS supports customer approaches by all-in-one-hand service with including full analytical support, complete documentation and outstanding project management to gain market success.

Tobias Timtner
Marketing Manager
Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Protagen Protein Services GmbH
Inselwiesenstraße 10
74076 Heilbronn, Germany

Tel.: +49 7131 74504-209
Fax: +49 7131 74504-299
phone +49 231 9742 61 00
email Protagen Protein Services (GmbH), Inselwiesenstraße 10, D-74076 Heilbronn
Print this page
Send to a friend
News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy


Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement